Aging Clinical Trials 2023

Aging Clinical Trials 2023

Aging research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in aging clinical trials today.

Trials for Mild Cognitive Impairment Patients

Trials for MCI Patients

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to aging

What are the top hospitals conducting aging research?

While clinical trials are commonly associated with finding new treatments for diseases like cancer, they also play a crucial role in the field of aging research. Several top hospitals across the United States have dedicated resources and expertise to explore innovative approaches to promote healthy aging. In Houston, M D Anderson Cancer Center takes the lead with seven ongoing trials focused specifically on aging. This renowned institution, known for its excellence in cancer research and treatment, recognizes the importance of understanding the complexities of aging as it relates to overall health and well-being. On another note, Washington University School of Medicine in Saint Louis is making strides in this domain with four active studies aimed at unraveling the mysteries of aging. Their commitment highlights how even institutions primarily focused on other medical fields recognize that addressing age-related concerns is essential for comprehensive patient care.

In Kansas City, MO, the Kansas City VA Medical Center stands out as a key location where three current clinical trials are underway focusing solely on promoting healthy aging among veterans. This specialized center acknowledges that our nation's heroes deserve not only proper medical attention but also tailored interventions to enhance their quality of life as they grow older. Meanwhile, researchers at the University of Michigan School of Nursing in Ann Arbor are actively engaged in three ongoing trials investigating various aspects related to optimal aging strategies.

Lastly but certainly not least Massachusetts General Hospital - located right in Boston- has embarked upon three intriguing clinical trials centered around age-related issues affecting individuals from diverse backgrounds.These endeavors demonstrate their dedication toward comprehending how we can improve health outcomes as people age regardless if there's existing illness or not.As more hospitals join forces through these significant efforts towards exploring novel opportunities within geriatric medicine an ever-increasing body knowledge emerges; one which promises brighter prospects catering holistic approach ensuring wellness during golden years

Which are the best cities for aging clinical trials?

When it comes to aging clinical trials, several cities emerge as key players in advancing research and understanding. Houston, Texas leads the way with 9 ongoing trials exploring treatments like Magnetic Resonance Imaging, Chemotherapy, and Observation. Boston, Massachusetts closely follows with 7 active studies focusing on interventions such as real tACS, Cognitive Training using Cogmed, and 8-hour Afternoon-Evening Sleep patterns. Cincinnati, Ohio contributes with 6 current trials investigating methods like My Sentence Builder. Additionally Montreal in Quebec offers 5 active trials examining treatments including Radiopharmaceutical 68Ga-DOTATATE and Group pelvic floor telerehabilitation while Ann Arbor in Michigan provides insight through its four ongoing projects like HealthyLifetime and Memory Retraining Exercises. These cities serve as important hubs for aging-related clinical trial research across various disciplines offering potential breakthroughs for improved elderly care in the future.

Which are the top treatments for aging being explored in clinical trials?

The quest to combat aging is at the forefront of scientific research, with promising treatments currently being explored in clinical trials. Here are some top contenders:

  • Metformin: With its potential anti-aging properties, metformin is under investigation in multiple clinical trials.
  • Rapamycin: Known for its immunosuppressive effects, rapamycin also shows promise in slowing down the aging process and extending lifespan.
  • Senolytics: These drugs target senescent cells that accumulate with age and have been found to improve healthspan.

As researchers delve deeper into these treatments, they offer hope for a future where we can better understand and potentially slow down the aging process.

What are the most recent clinical trials for aging?

Recent clinical trials are shedding light on potential interventions for aging, offering hope for enhanced quality of life in older adults. One such trial involves a healthy control group, which aims to better understand the aging process and identify factors that contribute to successful aging. Additionally, rhPSMA-7.3 is being investigated as a possible treatment option through its Phase 3 trial, providing insights into its effectiveness in addressing age-related challenges. Another study focuses on the use of transdermal nicotine patches in combating certain aspects of aging by exploring their impact on various age-related conditions. These innovative trials are paving the way toward healthier and more fulfilling lives for individuals as they navigate the journey of growing older.

What aging clinical trials were recently completed?

Recent advancements in aging research have seen the completion of several notable clinical trials. These trials aimed to explore new interventions and therapies that could potentially improve outcomes for older individuals. Although specific details may vary, some recent completed trials include investigations into the effects of novel drugs, lifestyle modifications, and interventions targeting age-related diseases. While each trial has its own unique focus, they collectively contribute to our understanding of aging processes and offer hope for potential strategies to enhance healthy aging in the future.